Paragonix Technologies, Inc.’s Post

Check out this post from Paragonix Technologies.

Yasuhiro Shudo, MD, Clinical Assistant Professor of Cardiothoracic Surgery, recently used the BAROguard Donor Lung Preservation System for the first time at Stanford University. The Stanford team used the device to enhance safety margins in the donor organ procurement, and preserve the donor bilateral lung during its journey to Stanford. The patient, who received a multiorgan liver and lung transplant, is doing well postoperatively and was recently discharged. "The airway pressure control is the strongest point of using this device. It has the potential to decrease primary graft dysfunction after transport or during ischemia-reperfusion," Dr. Shudo said. "Even in cases where the donor lung exhibits minor air leakage or suspected injury/trauma, this device may provide specific advantages by optimizing positive pressure on the donor lung." https://lnkd.in/egWQCnCD

Yasuhiro Shudo, MD, Clinical Assistant Professor of Cardiothoracic Surgery, recently used the BAROguard Donor Lung Preservation System for the first time at Stanford University. The Stanford team used the device to enhance safety margins in the donor organ procurement, and preserve the donor bilateral lung during its journey to Stanford. The patient, who received a multiorgan liver and lung transplant, is doing well postoperatively and was recently discharged. "The airway pressure control is the strongest point of using this device. It has the potential to decrease primary graft dysfunction after transport or during ischemia-reperfusion," Dr. Shudo said. "Even in cases where the donor lung exhibits minor air leakage or suspected injury/trauma, this device may provide specific advantages by optimizing positive pressure on the donor lung." https://lnkd.in/egWQCnCD

February is Heart Month and Duke Health is proud to have performed the most heart transplants of any other transplant center in 2023. Heart transplants are part of a group called thoracic transplants, which is one of the most challenging and complex areas of transplant. Thoracic transplants also include lung transplants, of which Duke has performed more than any other center in the world. Not only is the Duke Transplant Center team performing at a high volume, but they also perform at a high degree of complexity. The program has successfully completed the highest volume of some of the most difficult cases like combination heart and lung transplants, third double lung transplants, and our pioneering partial heart transplants. See more: https://bit.ly/49qrNB9 Duke Heart Center | Duke Surgery | #DukeCTSurgery | #HeartTransplant | #LungTransplant | #HeartMonth

Another paper presenting extremely low primary patency rates at 6 months (6,4%) and even in the short term (45%PP rate@30days) for endovascular deep venous arterialization. Once again, I underline that hybrid GSV arterialization is the best solution for long lasting results in feasible (GSV>3mm) no-option CLTI patients. Don't you think it is time to make it accessible to more patients? August Ysa Marta Lobato Bruno Migliara Daniel van den Heuvel Miguel Montero Baker Andrea Casini Konstantinos Stavroulakis European Society for Vascular Surgery Michiel Schreve Costantino Del Giudice, MD, PhD Steven Kum Percutaneous Deep Venous Arterialization in Patients with No-Option Critical Limb Ischemia Performed in an Office-Based Laboratory Setting https://lnkd.in/drU-8Xik

I’m happy to share that our case report has been published in the BMC Cardiothoracic surgery journal! 🫀 The case highlights an interesting cardiovascular condition and the importance of cardiac surgery in treating it. Huge thanks to the amazing cardiosurgeons Dr. Moath Nairat, Dr.Issa Al-Khdour, and Dr. Amro AlAqra. This is a great step in my future, and I hope it leads to more research and better treatments for heart conditions. Check out the full report here: https://lnkd.in/dVwaJbj7 #Cardiology #CardioSurgery #BMC #Research #Publication #case_reports

Today marks the last day of the German Society for Thoracic-, Cardiac and Vascular Surgery (#DGTHG) Conference. If you're attending, make sure not to miss out on two sessions that are sure to be informative and engaging. First up at 14:36 in Hall 4, there will be an Update on the #avneo ) (#Ozaki) Procedure presented by Prof. Dr. med. Markus Krane from München, Deutschland. Later in the day at 17:15 in Hall F, Dr Anatol Prinzing also from München, Deutschland, will present on the topic of Aortic Valve Neocuspidization for Younger Patients - Safe and Feasible? Make sure to attend these sessions for the latest insights on these important topics in the field of thoracic, cardiac, and vascular surgery. Sanamedi, Inc. AVNeo (Aortic Valve Neocuspidization)

In on-pump cardiac surgery, a network meta-analysis revealed that crystalloid priming strategies are associated with fewer perioperative red blood cell (RBC) transfusions compared to albumin priming, although the difference in postoperative blood loss between the two was not statistically significant. #Blood #CPB #Crystalloid #Transfusion

In on-pump cardiac surgery, a network meta-analysis revealed that crystalloid priming strategies are associated with fewer perioperative red blood cell (RBC) transfusions compared to albumin priming, although the difference in postoperative blood loss between the two was not statistically significant. #Blood #CPB #Crystalloid #Transfusion

Basel Ramlawi, MD, Chief of Cardiothoracic Surgery, Main Line Health, was a coauthor of a study in the Journal of the American College of Cardiology demonstrating a 26% relative reduction in hazard for all-cause mortality and disabling stroke with transcatheter vs. surgical aortic valve replacement in treatment of aortic stenosis. Findings were based on four-year outcomes of patients in the Evolut Low Risk Trial. https://bit.ly/3GQw04x